Stock futures were pointing to a slightly lower opening ahead of the Goldman Sachs testimony on Capitol hill later this morning.
Here are some of the early-market movers for Tuesday.
Biostar Pharmaceuticals, Inc. (BSPM)
The Chinese pharmaceutical company received approval from the Shaanxi State Food and Drug Administration to market its Xin Aoxing Oleanolic Acid Capsules for treating Hepatitis B. Shares were up 11.9% in pre-market trading.
Cirrus Logic, Inc. (CRUS)
The company, which manufactures precision signal processing components, posted fourth-quarter results of earnings of 16 cents per share and revenue of $62.6 million. Revenue increased 87% from the same period last year and shares gained 5.9% in pre-market trading.
Cavium Networks Inc (CAVM)
Shares of the semiconductor company were up 6.8% in pre-market trading after posting first-quarter results which beat expectations reporting non-GAAP earnings of 14 cents per share on revenue of $41.6 million. Analysts had estimated earnings of 11 cents per share and revenue of $40.73 million.
Digirad Corp. (DRAD)
Shares continued to move to gain another 6.7% in pre-market trading Tuesday following Monday’s announcement that it received FDA approval for its general-purpose portable medical imaging system.
China BAK Battery, Inc. (CBAK)
The Chinese manufacturer of lithium-ion batteries posted second-quarter earnings reporting a loss of four cents per share on revenue of $50.4 million. While revenue increased 23.5% from the same period last year, shares were down 8.2% in pre-market trading.
Zoran Corp (ZRAN)
Shares of the digital entertainment company slipped 6.6% in pre-market trading after reporting a first quarter adjusted loss of three cents per share. This was in-line with expectations but revenue of $90.5 million came in below analyst estimates of $92.62 million.
Business briefs: Community Health’s profits increaseChubb Corp 1Q Beats Estimates
